Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone + salmeterol versus higher-dose fluticasone on methacholine hyper-responsiveness in mild to moderate persistent asthma
2008-001027-59Phase 3Completed
- Sponsor
- University of Dundee
- Start
- Jul 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate and salmeterol in asthma (2 arms), sponsored by University of Dundee. Primary endpoint: Primary efficacy endpoint. Started Jul 2008; status: completed.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2008-001027-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001027-59.